In January 2026, health authorities in India’s West Bengal state announced an outbreak of the Nipah virus. This rare but severe viral infection has attracted global attention due to its high fatality rate and potential for human-to-human transmission. Local officials reported several confirmed cases of infection, and as part of rapid containment measures, up to 100 contacts — including physicians — were placed under quarantine.
The Nipah virus is not new to the world; it has been present in South and Southeast Asia for decades. However, outbreaks have typically been sporadic and unpredictable. This year’s situation is somewhat different, as the virus has re-emerged near Kolkata, one of India’s largest urban centers. This has raised concerns among public health experts and neighboring countries, which have already begun health screenings for travelers arriving from India.
What Is the Nipah Virus?
Nipah virus (NiV) is a zoonotic virus, meaning it primarily circulates in animals and can be transmitted to humans. It belongs to the genus Henipavirus within the Paramyxoviridae family. Simply put, fruit bats (genus Pteropus) serve as the natural reservoir of the virus. These bats carry the virus without showing symptoms and shed it through saliva, urine, and feces.
From an infectious disease perspective, according to the Cleveland Clinic, humans may become infected through the following routes:
-
Direct contact with infected animals, particularly bats or pigs.
-
Consumption of food contaminated with bat secretions, such as raw date palm sap or fruit contaminated with bat saliva or urine.
-
Close contact with an infected person, especially through exposure to bodily fluids such as saliva, blood, or respiratory secretions.
Human-to-human transmission has been documented in previous outbreaks, particularly within families and healthcare settings. The virus enters the body through mucous membranes (eyes, nose, mouth) and replicates rapidly, affecting critical systems such as the central nervous system and the respiratory tract.
Course of the Disease
After exposure, symptoms usually develop within 4–14 days. Early signs are nonspecific and resemble influenza, making early diagnosis challenging. These include fever, headache, muscle pain, vomiting, and sore throat. In more severe cases, the disease may progress to:
-
Respiratory distress
-
Encephalitis (inflammation of the brain)
-
Confusion, seizures, coma
Severe neurological involvement can develop rapidly; some patients may fall into a coma within 24–48 hours after the onset of neurological symptoms.
Fatality Rate
One of the defining features of Nipah virus infection is its high fatality rate. Based on global studies and outbreak reviews, deaths occur in approximately 40–75% of confirmed cases. According to PubMed, data from certain regions of India may be even more alarming. This rate is significantly higher than the overall fatality rate of COVID-19, which was globally around 2–3% (and even lower in many populations due to vaccination and improved treatment).
Clinical Severity
Beyond its high fatality rate, the Nipah virus can cause rapid neurological deterioration and severe respiratory disease. Survivors may experience long-term complications, including persistent seizures or personality changes due to brain damage.
Nipah virus infection is considerably more lethal than COVID-19 but less transmissible. A virus that combines both high fatality and high transmissibility would clearly pose an extreme threat; however, Nipah virus has not naturally demonstrated this combination to date.
| Characteristic | Nipah Virus | COVID-19 (SARS-CoV-2) |
|---|---|---|
| Case fatality rate | ~40–75% | ~2–3% globally |
| Transmission | Limited (close contact) | Highly transmissible (droplets, aerosols) |
| Treatment | No specific antiviral; supportive care | Vaccines available; targeted antiviral therapies |
| Pandemic potential | Possible but currently limited | Proven global pandemic capability |
Prevention and Protection
Since there is currently no widely approved vaccine or specific antiviral therapy against the Nipah virus, public health strategies are focused on prevention.
Personal protection measures:
-
Avoid consuming raw date palm sap or unwashed fruit that may be contaminated with bat secretions.
-
Maintain good hygiene, including frequent handwashing with soap or the use of alcohol-based sanitizers.
-
When caring for an infected individual, use personal protective equipment such as masks and gloves.
-
Avoid non-essential travel to Southeast Asia in the near future.
At present, there is no basis for panic in Georgia regarding this zoonotic virus. The virus has limited transmissibility, and to date, no cases of Nipah virus have been recorded in the Caucasus or the Middle East regions.
